(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

TUOTEEM

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

TUOTEEM

ST13

US500000079351828

Class

5

Filing

79351828

Registration

7147583

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

31

Latest update

12/26/2023

Trademark type

Word

Nice classes

5

Filing date

08/25/2022

Registration date

08/29/2023

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

08/29/2023

Last transaction

08/29/2023

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

4

Owner type

25

Owner location

CH

Examiner

COGAN, BRITTNEY LORRAINE

Law office

M50

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

NOVARTIS AG

Representatives

Maury M. Tepper, III Tepper & Eyster, PLLC

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune systemthe metabolic systemthe endocrine systemthe musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Publications

History of USPTO decisions and trademark events.

31 publications found

FINV

FINAL DECISION TRANSACTION PROCESSED BY IB

12/26/2023

FICS

FINAL DISPOSITION NOTICE SENT TO IB

12/04/2023

FIMP

FINAL DISPOSITION PROCESSED

12/04/2023

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

11/29/2023

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

08/29/2023

R.PR

REGISTERED-PRINCIPAL REGISTER

08/29/2023

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

06/13/2023

PUBO

PUBLISHED FOR OPPOSITION

06/13/2023

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

05/24/2023

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

05/10/2023

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

05/03/2023

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

05/03/2023

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

05/03/2023

ALIE

ASSIGNED TO LIE

05/02/2023

RFNT

REFUSAL PROCESSED BY IB

02/07/2023

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

02/01/2023

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

01/19/2023

RFRR

REFUSAL PROCESSED BY MPU

01/19/2023

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

11/08/2022

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

11/07/2022

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

11/07/2022

ECDR

TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS

11/07/2022

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

11/07/2022

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

11/07/2022

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

11/07/2022

CNRT

NON-FINAL ACTION WRITTEN

11/07/2022

DOCK

ASSIGNED TO EXAMINER

11/03/2022

MAFR

APPLICATION FILING RECEIPT MAILED

10/21/2022

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

10/17/2022

LIMI

LIMITATION FROM ORIGINAL APPLICATION ENTERED

10/14/2022

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

10/06/2022

Continuous trademark protection

Get notified about every new filing that threatens TUOTEEM or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.